{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T10:49:24Z","timestamp":1776509364510,"version":"3.51.2"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,18]]},"DOI":"10.7759\/cureus.107278","type":"journal-article","created":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T10:26:28Z","timestamp":1776507988000},"source":"Crossref","is-referenced-by-count":0,"title":["Gout Flare in Hospitalized Patients: Risk Factors and the Impact of Allopurinol Management"],"prefix":"10.7759","author":[{"given":"Mehrnoush","family":"Hassas Yeganeh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alaa","family":"Attabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar","family":"Jumaah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanda","family":"Saleh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arooba","family":"Malik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Balqees","family":"Ara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sajina","family":"Prabhakaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00569-9","article-title":"Gout","volume":"397","author":"Dalbeth N","year":"2021","unstructured":"Dalbeth N, Gosling AL, Gaffo A, Abhishek A. Gout. Lancet. 2021, 397:1843-55. 10.1016\/S0140-6736(21)00569-9","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp2203385","article-title":"Gout","volume":"387","author":"Mikuls TR","year":"2022","unstructured":"Mikuls TR. Gout. N Engl J Med. 2022, 387:1877-87. 10.1056\/NEJMcp2203385","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2013.06.026","article-title":"Increased risk of recurrent gout attacks with hospitalization","volume":"126","author":"Dubreuil M","year":"2013","unstructured":"Dubreuil M, Neogi T, Chen CA, Choi HK, Chaisson CE, Hunter DJ, Zhang Y. Increased risk of recurrent gout attacks with hospitalization. Am J Med. 2013, 126:1138-41.e1. 10.1016\/j.amjmed.2013.06.026","journal-title":"Am J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-216277","article-title":"Development of a prediction model for inpatient gout flares in people with comorbid gout","volume":"79","author":"Jatuworapruk K","year":"2020","unstructured":"Jatuworapruk K, Grainger R, Dalbeth N, Taylor WJ. Development of a prediction model for inpatient gout flares in people with comorbid gout. Ann Rheum Dis. 2020, 79:418-23. 10.1136\/annrheumdis-2019-216277","journal-title":"Ann Rheum Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab590","article-title":"The GOUT-36 prediction rule for inpatient gout flare in people with comorbid gout: derivation and external validation","volume":"61","author":"Jatuworapruk K","year":"2022","unstructured":"Jatuworapruk K, Grainger R, Dalbeth N, et al.. The GOUT-36 prediction rule for inpatient gout flare in people with comorbid gout: derivation and external validation. Rheumatology (Oxford). 2022, 61:1658-62. 10.1093\/rheumatology\/keab590","journal-title":"Rheumatology (Oxford)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.211203","article-title":"Hospitalizations for acute gout: process mapping the inpatient journey and identifying predictors of admission","volume":"49","author":"Russell MD","year":"2022","unstructured":"Russell MD, Nagra D, Clarke BD, et al.. Hospitalizations for acute gout: process mapping the inpatient journey and identifying predictors of admission. J Rheumatol. 2022, 49:725-30. 10.3899\/jrheum.211203","journal-title":"J Rheumatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/art.41247","article-title":"2020 American College of Rheumatology Guideline for the Management of Gout","volume":"72","author":"FitzGerald JD","year":"2020","unstructured":"FitzGerald JD, Dalbeth N, Mikuls T, et al.. 2020 American College of Rheumatology Guideline for the Management of Gout. Arthritis Rheumatol. 2020, 72:879-95. 10.1002\/art.41247","journal-title":"Arthritis Rheumatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.26640","article-title":"Serum urate and recurrent gout","volume":"331","author":"McCormick N","year":"2024","unstructured":"McCormick N, Yokose C, Challener GJ, Joshi AD, Tanikella S, Choi HK. Serum urate and recurrent gout. JAMA. 2024, 331:417-24. 10.1001\/jama.2023.26640","journal-title":"JAMA"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/art.42927","article-title":"Comparison of gout flares with the initiation of treat-to-target allopurinol and febuxostat: a post-hoc analysis of a randomized multicenter trial","volume":"76","author":"Barry A","year":"2024","unstructured":"Barry A, Helget LN, Androsenko M, et al.. Comparison of gout flares with the initiation of treat-to-target allopurinol and febuxostat: a post-hoc analysis of a randomized multicenter trial. Arthritis Rheumatol. 2024, 76:1552-9. 10.1002\/art.42927","journal-title":"Arthritis Rheumatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/acr.24180","article-title":"2020 American College of Rheumatology Guideline for the Management of Gout","volume":"72","author":"FitzGerald JD","year":"2020","unstructured":"FitzGerald JD, Dalbeth N, Mikuls T, et al.. 2020 American College of Rheumatology Guideline for the Management of Gout. Arthritis Care Res (Hoboken). 2020, 72:744-60. 10.1002\/acr.24180","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2024.08.003","article-title":"KDOQI US commentary on the KDIGO 2024 clinical practice guideline for the evaluation and management of CKD","volume":"85","author":"Navaneethan SD","year":"2025","unstructured":"Navaneethan SD, Bansal N, Cavanaugh KL, et al.. KDOQI US commentary on the KDIGO 2024 clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis. 2025, 85:135-76. 10.1053\/j.ajkd.2024.08.003","journal-title":"Am J Kidney Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2023.10.018","article-title":"KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"105","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group","year":"2024","unstructured":"Kidney Disease. Improving Global Outcomes (KDIGO) CKD Work Group: KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2024, 105:S117-314. 10.1016\/j.kint.2023.10.018","journal-title":"Kidney Int"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.semnephrol.2020.12.007","article-title":"The management of gout in renal disease","volume":"40","author":"Estiverne C","year":"2020","unstructured":"Estiverne C, Mount DB. The management of gout in renal disease. Semin Nephrol. 2020, 40:600-13. 10.1016\/j.semnephrol.2020.12.007","journal-title":"Semin Nephrol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2024.05.033","article-title":"Controversies and practical management of patients with gout and chronic kidney disease","volume":"106","author":"Johnson RJ","year":"2024","unstructured":"Johnson RJ, Mandell BF, Schlesinger N, et al.. Controversies and practical management of patients with gout and chronic kidney disease. Kidney Int. 2024, 106:573-82. 10.1016\/j.kint.2024.05.033","journal-title":"Kidney Int"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/art.38203","article-title":"Use of diuretics and risk of incident gout: a population-based case-control study","volume":"66","author":"Bruderer S","year":"2014","unstructured":"Bruderer S, Bodmer M, Jick SS, Meier CR. Use of diuretics and risk of incident gout: a population-based case-control study. Arthritis Rheumatol. 2014, 66:185-96. 10.1002\/art.38203","journal-title":"Arthritis Rheumatol"},{"key":"ref16","article-title":"Recent diuretic use and the risk of recurrent gout attacks: the online case-crossover gout study","volume":"33","author":"Hunter DJ","year":"2006","unstructured":"Hunter DJ, York M, Chaisson CE, Woods R, Niu J, Zhang Y. Recent diuretic use and the risk of recurrent gout attacks: the online case-crossover gout study. J Rheumatol. 2006, 33:1341-5.","journal-title":"J Rheumatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/484532-gout-flare-in-hospitalized-patients-risk-factors-and-the-impact-of-allopurinol-management","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T10:26:29Z","timestamp":1776507989000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/484532-gout-flare-in-hospitalized-patients-risk-factors-and-the-impact-of-allopurinol-management"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,18]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.107278","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,18]]}}}